Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society

Korean Breast Cancer Society

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were surgically treated for primary breast cancer between 1987 and 2011 in Korea. All data were collected by the Korean Breast Cancer Society (KBCS) online breast cancer registry. Each hospital serologically examined the ABO blood types of patients before surgery. There was no significant difference in overall survival (OS) or breast cancer-specific survival (BCSS) among ABO blood types. Type of surgery; T stage; N stage; histologic grade; status of estrogen receptor, progesterone receptor, and HER2; and chemotherapy were significant prognostic factors of OS and BCSS in univariate analysis and multivariate analyses. Compared to women with blood type O, there was a difference in OS and BCSS for blood type A, blood type B, or blood type AB. Compared to blood group non-O, patients with blood group O were more likely to have favorable prognosis when younger than 40 years. Further follow-up studies are necessary to clarify the role of the impact of ABO blood types on prognosis of breast cancer.

Original languageEnglish
Article number118
JournalMedical Oncology
Volume34
Issue number6
DOIs
Publication statusPublished - 2017 Jun 1

Fingerprint

Breast Neoplasms
Survival
Blood Group Antigens
Progesterone Receptors
Korea
Estrogen Receptors
Registries
Multivariate Analysis
Retrospective Studies
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Cancer Research

Cite this

@article{c8123382fbd14ca19a557b8a4c46fc8c,
title = "Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society",
abstract = "The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were surgically treated for primary breast cancer between 1987 and 2011 in Korea. All data were collected by the Korean Breast Cancer Society (KBCS) online breast cancer registry. Each hospital serologically examined the ABO blood types of patients before surgery. There was no significant difference in overall survival (OS) or breast cancer-specific survival (BCSS) among ABO blood types. Type of surgery; T stage; N stage; histologic grade; status of estrogen receptor, progesterone receptor, and HER2; and chemotherapy were significant prognostic factors of OS and BCSS in univariate analysis and multivariate analyses. Compared to women with blood type O, there was a difference in OS and BCSS for blood type A, blood type B, or blood type AB. Compared to blood group non-O, patients with blood group O were more likely to have favorable prognosis when younger than 40 years. Further follow-up studies are necessary to clarify the role of the impact of ABO blood types on prognosis of breast cancer.",
author = "{Korean Breast Cancer Society} and Sungmin Park and Kim, {Ku Sang} and Kim, {Jeong Soo} and Wonshik Han and Byeongwoo Park and Seokwon Lee and Jeon, {Ye Won} and Lee, {Se Kyung} and Jonghan Yu and Lee, {Jeong Eon} and Kim, {Seok Won} and Nam, {Seok Jin}",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s12032-017-0974-6",
language = "English",
volume = "34",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "6",

}

Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society. / Korean Breast Cancer Society.

In: Medical Oncology, Vol. 34, No. 6, 118, 01.06.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society

AU - Korean Breast Cancer Society

AU - Park, Sungmin

AU - Kim, Ku Sang

AU - Kim, Jeong Soo

AU - Han, Wonshik

AU - Park, Byeongwoo

AU - Lee, Seokwon

AU - Jeon, Ye Won

AU - Lee, Se Kyung

AU - Yu, Jonghan

AU - Lee, Jeong Eon

AU - Kim, Seok Won

AU - Nam, Seok Jin

PY - 2017/6/1

Y1 - 2017/6/1

N2 - The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were surgically treated for primary breast cancer between 1987 and 2011 in Korea. All data were collected by the Korean Breast Cancer Society (KBCS) online breast cancer registry. Each hospital serologically examined the ABO blood types of patients before surgery. There was no significant difference in overall survival (OS) or breast cancer-specific survival (BCSS) among ABO blood types. Type of surgery; T stage; N stage; histologic grade; status of estrogen receptor, progesterone receptor, and HER2; and chemotherapy were significant prognostic factors of OS and BCSS in univariate analysis and multivariate analyses. Compared to women with blood type O, there was a difference in OS and BCSS for blood type A, blood type B, or blood type AB. Compared to blood group non-O, patients with blood group O were more likely to have favorable prognosis when younger than 40 years. Further follow-up studies are necessary to clarify the role of the impact of ABO blood types on prognosis of breast cancer.

AB - The purpose of this study was to investigate the relationship between ABO blood types and breast cancer survival in young Korean patients. This was a retrospective study of 115,474 patients who were surgically treated for primary breast cancer between 1987 and 2011 in Korea. All data were collected by the Korean Breast Cancer Society (KBCS) online breast cancer registry. Each hospital serologically examined the ABO blood types of patients before surgery. There was no significant difference in overall survival (OS) or breast cancer-specific survival (BCSS) among ABO blood types. Type of surgery; T stage; N stage; histologic grade; status of estrogen receptor, progesterone receptor, and HER2; and chemotherapy were significant prognostic factors of OS and BCSS in univariate analysis and multivariate analyses. Compared to women with blood type O, there was a difference in OS and BCSS for blood type A, blood type B, or blood type AB. Compared to blood group non-O, patients with blood group O were more likely to have favorable prognosis when younger than 40 years. Further follow-up studies are necessary to clarify the role of the impact of ABO blood types on prognosis of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85019215892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019215892&partnerID=8YFLogxK

U2 - 10.1007/s12032-017-0974-6

DO - 10.1007/s12032-017-0974-6

M3 - Article

VL - 34

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 6

M1 - 118

ER -